HDMA revises 856 Advance Ship Notice documentation
Latest version is 'based on our evolving understanding of the DSCSA'
Having issued a preliminary version of 856 ASN in April, the Healthcare Distribution Management Assn. is now back with an updated, “formal” version, available at the HDMA Store. The document is relevant mostly to IT and database-management personnel who need to adapt the existing ASN data fields to the requirements of the Drug Supply Chain Security Act passed last November. That HDMA has come out twice with updates is a testament to the urgency of getting data-forwarding practices in order among US drug distributors: come January, distributors will need to be able to verify shipments (at the lot level) to pharmacies and other customers. This is the legislated mandate from Congress when it passed the Drug Quality and Security Act (of which DSCSA is a part); FDA is on call to Congress to issue guidelines for drug tracking by late November. How well everybody—manufacturers (who need to put appropriate labels on their product cartons), wholesalers, retailers and FDA—will meet these mandates remains to be seen.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
